sodium 3-methyl-2-oxovalerate
Modify Date: 2024-01-14 15:36:31
sodium 3-methyl-2-oxovalerate structure
|
Common Name | sodium 3-methyl-2-oxovalerate | ||
|---|---|---|---|---|
| CAS Number | 3715-31-9 | Molecular Weight | 152.12400 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C6H9NaO3 | Melting Point | 204-206 ℃(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
Use of sodium 3-methyl-2-oxovalerate3-Methyl-2-oxovaleric acid (sodium) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | 3-Methyl-2-oxovaleric Acid Sodium Salt |
|---|---|
| Synonym | More Synonyms |
| Description | 3-Methyl-2-oxovaleric acid (sodium) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Melting Point | 204-206 ℃(lit.) |
|---|---|
| Molecular Formula | C6H9NaO3 |
| Molecular Weight | 152.12400 |
| Exact Mass | 152.04500 |
| PSA | 57.20000 |
| Storage condition | 2-8°C |
|
Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
Biochim. Biophys. Acta 1639(3) , 232-8, (2003) Neurological dysfunction is a common finding in patients with maple syrup urine disease (MSUD). However, the mechanisms underlying the neuropathology of brain damage in this disorder are poorly known.... |
|
|
Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
J. Inherit. Metab. Dis. 22(6) , 706-22, (1999) In maple syrup urine disease (MSUD), branched-chain L-amino (BCAA) and 2-oxo acids (BCOA) accumulate in body fluids owing to an inherited deficiency of branched-chain 2-oxo acid dehydrogenase complex ... |
|
|
alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
Metab. Brain Dis. 20(2) , 155-67, (2005) Maple syrup urine disease (MSUD) is an inherited neurometabolic disorder caused by deficiency of branched-chain alpha-keto acid dehydrogenase complex activity which leads to tissue accumulation of the... |
| 3-methyl-2-oxopentanoic acid sodium salt |
| MFCD00002584 |
| EINECS 266-503-4 |